The September 2019 AHPA Report includes guidance on herbal supplement labeling, AHPA at AOAC INTERNATIONAL, climate action in the health and nutrition industry, the glyphosate debate, GRAS: Meeting the burden of persuasion, AHPA at SupplySide West and more.
The August 2019 AHPA Report includes an analysis of FDA recall data, recent CA Prop 65 enforcement trends, the first warning letter addressing FSVP, insights from the Hemp-CBD Supplement Congress and updated guidance for hemp-CBD.
The July 2019 AHPA Report includes an open letter from AHPA President Michael McGuffin on his 20 years as AHPA President, recent CBD advocacy, AHPA's recommendations for supplement innovation, AHPA email alerts and much more.
2020 Annual Fund Sponsors
AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.